Interleukin 23p19 inhibitors in chronic plaque psoriasis with focus on mirikizumab: A narrative review-Reference-Cited by-同舟云学术

Interleukin 23p19 inhibitors in chronic plaque psoriasis with focus on mirikizumab: A narrative review

Published:2020-07 Issue:4 Volume:33 Page:
ISSN:1396-0296
Container-title:Dermatologic Therapy
language:en
Short-container-title:Dermatologic Therapy

Author:

Salimi Sohrab¹,Yamauchi Paul S.²³,Thakur Rohini⁴,Weinberg Jeffrey M.⁵,Kircik Leon⁵,Abdelmaksoud Ayman⁶^ORCID,Wollina Uwe⁷^ORCID,Lotti Torello⁸^ORCID,Sharma Aseem⁹^ORCID,Grabbe Stephan¹⁰,Goldust Mohamad¹⁰¹¹¹²^ORCID

Affiliation:

1. Department of Anesthesiology, School of Medicine Imam Hossein Hospital, Shahid Beheshti University of Medical Sciences Tehran Iran

2. Dermatology Institute and Skin Care Center Santa Monica California USA

3. Division of Dermatology David Geffen School of Medicine at University of California Los Angeles California USA

4. Dermatology, Venereology and Leprology Consultant Dermatology and Cosmetology Columbia Asia Hospital Patiala Punjab India

5. Icahn School of Medicine at Mount Sinai New York New York USA

6. Mansoura Dermatology Venerology and Leprology Hospital Mansoura Egypt

7. Department of Dermatology and Allergology, Städtisches Klinikum Dresden Academic Teaching Hospital of the Technical University of Dresden Dresden Germany

8. Department of Dermatology University of Studies Guglielmo Marconi Rome Italy

9. Dermatology Unit Skin Saga Centre for Dermatology Mumbai India

10. Department of Dermatology University Medical Center of the Johannes Gutenberg University Mainz Germany

11. University of Rome G. Marconi Rome Italy

12. Department of Dermatology University Hospital Basel Basel Switzerland

Publisher

Wiley

Subject

Dermatology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/dth.13800

Reference55 articles.

1. Local reinfusion of B10 cells is effective in the treatment of pustular psoriasis

2. NB‐UVB irradiation attenuates inflammatory response in psoriasis

3. Failure of response to combination therapy of adalimumab and infliximab in a recalcitrant patient of severe psoriasis and major thalassemia: A case report

4. When the old works better than the new a case of severe nail psoriasis successfully treated with acitretin after failure of two biologic regimens;Graceffa D;Dermatol Ther,2020

5. Tapering and discontinuation of systemic medications in psoriasis patients with low disease activity;Shi L;Dermatol Ther,2020

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Safety and Pharmacokinetics of Single‐Dose Mirikizumab in Chinese Healthy Participants: Results From a Phase 1 Study;Clinical Pharmacology in Drug Development;2024-09-04

2. The holistic approach to psoriasis patients with comorbidities: the role of investigational drugs;Expert Opinion on Investigational Drugs;2023-06-03

3. Anti-IL23 biologic therapies in the treatment of psoriasis: real-world experience versus clinical trials data;Immunologic Research;2023-01-04

4. What’s new and what’s next for biological and targeted synthetic treatments in psoriatic arthritis?;Expert Opinion on Biological Therapy;2022-12-02

5. Loss of Indoleamine-2,3-Dioxygenase-1 (IDO1) in Knockout Mice Does Not Affect the Development of Skin Lesions in the Imiquimod-Induced Mouse Model of Psoriasis;International Journal of Tryptophan Research;2022-01